SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced the appointment of Michael Buckner as chief legal officer, effective today. Buckner brings nearly three decades of experience as a senior global legal executive, with a proven track record of building and leading high-performing teams and deep expertise in complex transactions and regulatory environments. […]
Collaboration supports global LRRK2 Investigative Therapeutics Exchange (LITE) to accelerate development of reliable biomarkers for Parkinson’s disease ZURICH, Switzerland – Biognosys Group, a leading provider of proteomics, metabolomics, and lipidomics solutions, today announced a major collaboration with The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to advance the development of highly sensitive and quantitative […]
WALTHAM, Mass. — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a strategic collaboration with Precision Health Research, Singapore (PRECISE) to advance the PRECISE-SG100K study, one of the region’s most ambitious and diverse population-scale biobank initiatives. The collaboration reflects growing investments from national population studies looking to harness proteomics […]
Seer’s Proteograph will be used to generate enhanced proteomic insights in one of the world’s largest multi-omic health studies REDWOOD CITY, Calif. — Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that its Proteograph® Product Suite, has been selected as the mass spectrometry-based proteomic workflow to deeply profile the […]
BILLERICA, Mass. — Bruker Corporation (Nasdaq: BRKR) announces the appointment of Mr. Thierry L. Bernard to serve on its Board of Directors, effective as of today. Mr. Bernard is an international life-science tools and diagnostics industry executive with decades of relevant leadership, strategic and operational experience. Thierry Bernard Frank H. Laukien, the Chairman, President and CEO […]
US PTAB Revokes Sole Independent and Other Central Claims of U.S. Patent 11,435,360 SCHLIEREN, Switzerland & MUNICH — PreOmics GmbH and Biognosys AG today announced a favorable outcome in an inter partes review (IPR) proceeding IPR2024‑01473 before the U.S. Patent Trial and Appeal Board (PTAB). The PTAB has revoked the central claims of U.S. Patent […]
COLUMBIA, Md. — Shimadzu Scientific Instruments Inc., a Shimadzu Group company, has officially opened its new research and development (R&D) facility in South San Francisco, California. Since April 2024, SSI has been enhancing its R&D division with a focus on developing analytical instruments, software, applications and lab automation solutions tailored to the needs of pharmaceutical […]
23 claims of U.S. Patent No. 11,435,360 remain valid, supporting Seer’s Proteograph® Product Suite REDWOOD CITY, Calif. — Seer, Inc. (Nasdaq: SEER), a leader in deep, unbiased proteomic insights, today announced that the Patent Trial and Appeal Board (“PTAB”) of the U.S. Patent and Trademark Office issued a Final Written Decision on March 23, 2026, […]
Shimadzu Corporation has committed JPY 1 billion to the “Innovation Kyoto 2026 Investment Limited Partnership (KYOTO‑iCAP Fund III),” established by Kyoto University Innovation Capital Co., Ltd. (Kyoto). Kyoto iCAP has supported early-stage startups aiming to commercialize research outcomes from Kyoto University and other Japanese national universities through the ” Innovation Kyoto 2016 Investment Limited Partnership […]
Labware for 3D cell culture, low-bind labware, and glycan analysis kits are designed to accelerate life science innovation. S-BIO’s labware for 3D cell culture brings the reliable performance and reproducibility that our customers need when modeling tumor microenvironments or optimizing stem cell workflows.” — Theresa Schaub, Division President of Cosmo Bio USA CARLSBAD, CA, UNITED […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
